11β-hydroxylase deficiency screening: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== ==Screening== ==References== {{WikiDoc Help Menu}} {{WikiDoc Sources}}") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{}} | {{Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Revision as of 15:52, 27 January 2016
|
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
11β-hydroxylase deficiency screening On the Web |
|
American Roentgen Ray Society Images of 11β-hydroxylase deficiency screening |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
|
Risk calculators and risk factors for 11β-hydroxylase deficiency screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]